Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
about
In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging.N-Succinimidyl 3-((4-(4-[(18)F]fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate ([(18)F]SFBTMGMB): a residualizing label for (18)F-labeling of internalizing biomoleculesDistinct antibody species: structural differences creating therapeutic opportunitiesPreclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.Improving the targeting of therapeutics with single-domain antibodies.New insights into the pretargeting approach to image and treat tumours.Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases.Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies.Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers.Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo.Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.Crystal structure of an L chain optimised 14F7 anti-ganglioside Fv suggests a unique tumour-specificity through an unusual H-chain CDR3 architectureSubcellular Targeting of Theranostic Radionuclides
P2860
Q27342927-7669FCD2-6F96-4FA7-AB8D-79DA17435416Q35674555-46E570AB-37FE-49D2-8A95-467F30CDC9D1Q36484022-0E74B356-F50F-48AE-8D39-370A2B126951Q36945545-59F5F1A7-AA7E-4A3C-9E2A-2899269B0F22Q36963554-AE381486-4C97-4037-9011-14342066DA8BQ37085052-5342A00A-6A20-4363-A914-ADC814F09389Q38675117-857CD8AE-0644-4B22-BDCF-B0E57DFCBC45Q38976879-323B81EA-65F0-4B94-9694-11DDE5384905Q39002539-F37045E2-42DD-4A08-A04C-8C658701C7D0Q39793253-DC2EE597-C6B2-485F-B224-503F87779879Q41382042-0EC04FBC-D462-4098-8EC8-2F54E4253108Q41455532-228FD98A-C1C6-4B51-8BCF-058EFA5684B3Q47099672-1723675C-7442-4738-B04B-472F3FC4C971Q47134203-885B2EC0-1568-403B-9910-4DAC9D5C57FCQ47155090-A38E8603-3625-45C5-BE23-A02DE4074CA8Q48192595-8EC51337-03ED-47F0-9D43-F177D034B9B4Q48509449-C207BA37-CF2D-4C49-B7A5-8CC10057A7B1Q49167649-4FE44B0E-FD41-49B5-BDB7-E2D5BF4F3085Q52362264-F7386001-067B-42DB-B16C-CFFA32FD3DAFQ58378477-8406F325-AB93-41C6-ADD2-0D3E075B7170Q58764832-23B8F536-E44E-405F-8369-3A0A474158C0
P2860
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
@en
type
label
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
@en
prefLabel
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
@en
P2093
P2860
P50
P921
P1476
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
@en
P2093
Matthias D'Huyvetter
Tony Lahoutte
Vicky Caveliers
P2860
P304
P356
10.1517/17425247.2014.941803
P407
P5008
P577
2014-07-18T00:00:00Z
2014-12-01T00:00:00Z